Dr. Fred Saad on Galeterone and Xtandi
Embed Code (recommended way)
Embed Code (Iframe alternative)
Please login or signup to use this feature.

Dr. Fred Saad of the University of Montreal Hospital Center talks about why the new drug agent - galeterone - is important in targeting certain variants of the androgen receptor and why galeterone is seen as viable within the new class of drugs of benefit to patients experiencing castrate resistance to Xtandi

Licence : All Rights Reserved